OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
Weijun Wei, Qiufang Liu, Dawei Jiang, et al.
Advanced Science (2020) Vol. 7, Iss. 13
Open Access | Times Cited: 28
Weijun Wei, Qiufang Liu, Dawei Jiang, et al.
Advanced Science (2020) Vol. 7, Iss. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
Congcong Wang, Ning Li, Yutian Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Congcong Wang, Ning Li, Yutian Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
Yi‐Ting Chen, Jieling Ning, Wenjie Cao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 92
Yi‐Ting Chen, Jieling Ning, Wenjie Cao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 92
State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET
Marion Chomet, Guus A.M.S. van Dongen, Daniëlle J. Vugts
Bioconjugate Chemistry (2021) Vol. 32, Iss. 7, pp. 1315-1330
Open Access | Times Cited: 62
Marion Chomet, Guus A.M.S. van Dongen, Daniëlle J. Vugts
Bioconjugate Chemistry (2021) Vol. 32, Iss. 7, pp. 1315-1330
Open Access | Times Cited: 62
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 47
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 47
Metal‐Cyclic Dinucleotide Nanomodulator‐Stimulated STING Signaling for Strengthened Radioimmunotherapy of Large Tumor
Duo Wang, Tianqi Nie, Cuiqing Huang, et al.
Small (2022) Vol. 18, Iss. 41
Closed Access | Times Cited: 43
Duo Wang, Tianqi Nie, Cuiqing Huang, et al.
Small (2022) Vol. 18, Iss. 41
Closed Access | Times Cited: 43
Optical diagnostic imaging and therapy for thyroid cancer
Chengying Shao, Zhenfang Li, Chengchi Zhang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100441-100441
Open Access | Times Cited: 41
Chengying Shao, Zhenfang Li, Chengchi Zhang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100441-100441
Open Access | Times Cited: 41
Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
You Zhang, Di Zhang, Shuxian An, et al.
Research (2023) Vol. 6, pp. 0077-0077
Open Access | Times Cited: 32
You Zhang, Di Zhang, Shuxian An, et al.
Research (2023) Vol. 6, pp. 0077-0077
Open Access | Times Cited: 32
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Seyed Esmaeil Ahmadi, Ashkan Shabannezhad, Amir Kahrizi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Seyed Esmaeil Ahmadi, Ashkan Shabannezhad, Amir Kahrizi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 11
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 11
ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053
Cheng Wang, Yumei Chen, Yun Nan Hou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 9, pp. 2749-2760
Open Access | Times Cited: 49
Cheng Wang, Yumei Chen, Yun Nan Hou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 9, pp. 2749-2760
Open Access | Times Cited: 49
ImmunoPET imaging of human CD8+ T cells with novel 68Ga-labeled nanobody companion diagnostic agents
Haitao Zhao, Chao Wang, Yanling Yang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 44
Haitao Zhao, Chao Wang, Yanling Yang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 44
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
Reyhaneh Manafi‐Farid, Bahar Ataeinia, Shaghayegh Ranjbar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Reyhaneh Manafi‐Farid, Bahar Ataeinia, Shaghayegh Ranjbar, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Emerging Biomaterials Imaging Antitumor Immune Response
Xianbin Ma, Meng‐Jie Zhang, Jingting Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 42
Closed Access | Times Cited: 29
Xianbin Ma, Meng‐Jie Zhang, Jingting Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 42
Closed Access | Times Cited: 29
Potential of uPAR, αvβ6 Integrin, and Tissue Factor as Targets for Molecular Imaging of Oral Squamous Cell Carcinoma: Evaluation of Nine Targets in Primary Tumors and Metastases by Immunohistochemistry
Mads Lawaetz, Anders Christensen, Karina Juhl, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3853-3853
Open Access | Times Cited: 12
Mads Lawaetz, Anders Christensen, Karina Juhl, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3853-3853
Open Access | Times Cited: 12
Radioiodine based biomedical carriers for cancer theranostics
Jingru Guo, Hehua Xiong, Huihui Liu, et al.
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215430-215430
Closed Access | Times Cited: 11
Jingru Guo, Hehua Xiong, Huihui Liu, et al.
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215430-215430
Closed Access | Times Cited: 11
Advances in metal-based nano drugs and diagnostic probes for tumor
Jiayue Ding, Zhijing He, Yujia Zhai, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215594-215594
Closed Access | Times Cited: 11
Jiayue Ding, Zhijing He, Yujia Zhai, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215594-215594
Closed Access | Times Cited: 11
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2
Weijun Wei, Di Zhang, You Zhang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 305-314
Open Access | Times Cited: 19
Weijun Wei, Di Zhang, You Zhang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 305-314
Open Access | Times Cited: 19
[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
Ziqing Zeng, Liqiang Li, Jinping Tao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 5, pp. 1221-1232
Closed Access | Times Cited: 10
Ziqing Zeng, Liqiang Li, Jinping Tao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 5, pp. 1221-1232
Closed Access | Times Cited: 10
Claudin18.2-targeted cancer theranostics.
Di Zhang, Gang Huang, Jianjun Liu, et al.
PubMed (2023) Vol. 13, Iss. 2, pp. 64-69
Closed Access | Times Cited: 9
Di Zhang, Gang Huang, Jianjun Liu, et al.
PubMed (2023) Vol. 13, Iss. 2, pp. 64-69
Closed Access | Times Cited: 9
Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053
Weijun Wei, Di Zhang, Cheng Wang, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 10, pp. 3502-3510
Closed Access | Times Cited: 16
Weijun Wei, Di Zhang, Cheng Wang, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 10, pp. 3502-3510
Closed Access | Times Cited: 16
Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update
Kateryna Matiash, Clayton S. Lewis, Vladimir Y. Bogdanov
Cancers (2021) Vol. 13, Iss. 18, pp. 4652-4652
Open Access | Times Cited: 12
Kateryna Matiash, Clayton S. Lewis, Vladimir Y. Bogdanov
Cancers (2021) Vol. 13, Iss. 18, pp. 4652-4652
Open Access | Times Cited: 12
Annotating BCMA Expression in Multiple Myelomas
Weijun Wei, You Zhang, Di Zhang, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 10, pp. 3492-3501
Closed Access | Times Cited: 11
Weijun Wei, You Zhang, Di Zhang, et al.
Molecular Pharmaceutics (2021) Vol. 19, Iss. 10, pp. 3492-3501
Closed Access | Times Cited: 11
ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers
Chenyi Liang, Wei Huang, You Zhang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 4184-4195
Closed Access | Times Cited: 4
Chenyi Liang, Wei Huang, You Zhang, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 4184-4195
Closed Access | Times Cited: 4
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy
Zhao Zou, Linhong Zhong
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101403-101403
Open Access | Times Cited: 1
Zhao Zou, Linhong Zhong
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101403-101403
Open Access | Times Cited: 1
